Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia; Griffith University School of Medicine, Gold Coast, Australia.
School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia.
Heart Lung. 2024 Nov-Dec;68:373-380. doi: 10.1016/j.hrtlng.2024.09.001. Epub 2024 Sep 10.
Sex differences in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) susceptibility, illness severity, and hospital course are widely acknowledged. The effects of sex on outcomes experienced by patients with severe Coronavirus Disease 2019 (COVID-19) admitted to the intensive care unit (ICU) remains unknown.
To determine the effects of sex on ICU mortality in patients with COVID-19 METHODS: This retrospective analysis of an international multi-center prospective observational database included adults admitted to ICU for treatment of acute COVID-19 between 1st January 2020 and 30th June 2022. The primary outcome was ICU mortality. Multivariable Cox regression was used to ascertain the hazard of death (Hazard Ratio=HR) adjusted for pre-selected covariates. The secondary outcome was sex differences in complications of COVID-19 during hospital stay.
Overall, 10,259 patients (3,314 females, 6,945 males) were included with a median age of 60 (interquartile range [IQR]=49-68) and 59 (IQR=49-67) years, respectively. Baseline characteristics were similar between sexes. More females were non-smokers (65% vs. 44 %, p < 0.01) and obese (39% vs. 30 %, p < 0.01), compared to males. Also, males received greater ICU intervention (mechanical ventilation, prone ventilation, vasopressors, and tracheostomy) than females. Males had a greater hazard of death (compared to females, HR=1.14; 95 % CI=1.02-1.26). Adjustment for complications during hospital stay did not alter the hazard of death (HR=1.16; 95 % CI=1.05-1.28). Males had a significantly elevated hazard of death among patients who received ECMO (HR=1.24; 95 % CI=1.01-1.53). Male sex was associated with cardiac arrest (adjusted OR [aOR]=1.37; 95 % CI=1.16-1.62) and PE (aOR=1.28; 95 % CI=1.06-1.55).
Among patients admitted to ICU for severe COVID-19, males experienced higher severity of illness and more frequent intervention than females. Ultimately, the hazard of death was moderately elevated in males compared to females despite greater PE and cardiac arrest.
性别与严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)易感性、疾病严重程度和住院过程中的差异已得到广泛认可。性别的影响对因严重 2019 年冠状病毒病(COVID-19)而入住重症监护病房(ICU)的患者的预后仍不清楚。
确定性别对 COVID-19 患者 ICU 死亡率的影响
本研究是对一个国际多中心前瞻性观察数据库的回顾性分析,纳入了 2020 年 1 月 1 日至 2022 年 6 月 30 日期间因急性 COVID-19 入住 ICU 治疗的成年人。主要结局是 ICU 死亡率。多变量 Cox 回归用于确定校正预先选择的协变量后的死亡风险(危险比[HR])。次要结局是住院期间 COVID-19 并发症的性别差异。
共有 10259 名患者(3314 名女性,6945 名男性)纳入研究,中位年龄为 60 岁(四分位距[IQR]=49-68)和 59 岁(IQR=49-67)。性别间基线特征相似。与男性相比,更多的女性不吸烟(65%比 44%,p < 0.01)和肥胖(39%比 30%,p < 0.01)。此外,与女性相比,男性接受了更多的 ICU 干预(机械通气、俯卧位通气、血管加压素和气管切开术)。与女性相比,男性的死亡风险更高(HR=1.14;95%置信区间=1.02-1.26)。调整住院期间的并发症并未改变死亡风险(HR=1.16;95%置信区间=1.05-1.28)。在接受 ECMO 治疗的患者中,男性的死亡风险显著升高(HR=1.24;95%置信区间=1.01-1.53)。男性与心脏骤停(调整后的比值比[aOR]=1.37;95%置信区间=1.16-1.62)和肺栓塞(aOR=1.28;95%置信区间=1.06-1.55)相关。
在因严重 COVID-19 而入住 ICU 的患者中,男性的疾病严重程度和干预频率均高于女性。尽管男性出现更多的 PE 和心脏骤停,但与女性相比,男性的死亡风险仍适度升高。